(Boursier.com) — The Combined General Meeting of Shareholders of Sanofi met on April 30, under the chairmanship of Frédéric Oudéa. All resolutions put to the vote were adopted by its shareholders.
The Meeting notably approved the corporate accounts and the consolidated accounts for the 2023 financial year.
It has decided to distribute an ordinary annual dividend of 3.76 euros per share. Its payment will take place on May 15.
To the Board of Directors
The Meeting also approved the renewal of the directorships of Rachel Duan and Lise Kingo, as well as the appointment of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy, all qualified as independent directors.
On the recommendation of the Nominations, Governance and CSR Committee, the Board of Directors appointed Clotilde Delbos as a member of the Audit Committee and the Compensation Committee, Anne-Françoise Nesmes as a member of the Compensation Committee. audit and John Sundy as a member of the Scientific Committee. Antoine Yver becomes Chairman of the Scientific Committee and member of the Strategic Reflection Committee.
At the end of this Meeting, the Board of Directors is temporarily composed of 17 directors, including two directors representing employees. It has an independence rate of 80% and a male/female diversity rate of 47%. It also has 8 directors of foreign nationality, i.e. a rate of 47%.
©2024 Boursier.com